DexCom, Inc. (DXCM) stands at the forefront of innovation in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, DexCom is renowned for its cutting-edge continuous glucose monitoring (CGM) systems, a vital tool for diabetes management. As the prevalence of diabetes continues to rise globally, DexCom’s solutions serve a critical need, offering investors a potentially lucrative opportunity in a rapidly expanding market.

DexCom’s current market capitalization is a robust $28.64 billion, reflecting its significant footprint in the healthcare industry. The company’s stock, priced at $73.04, has seen a slight decrease with a recent price change of -0.96 (-0.01%)….